Cargando…

Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496059/
https://www.ncbi.nlm.nih.gov/pubmed/37151180
http://dx.doi.org/10.1002/npr2.12343
_version_ 1785105028118216704
collection PubMed
description
format Online
Article
Text
id pubmed-10496059
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104960592023-09-13 Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022] Neuropsychopharmacol Rep Case Reports John Wiley and Sons Inc. 2023-05-07 /pmc/articles/PMC10496059/ /pubmed/37151180 http://dx.doi.org/10.1002/npr2.12343 Text en © 2023 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]
title Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]
title_full Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]
title_fullStr Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]
title_full_unstemmed Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]
title_short Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022]
title_sort withdrawal: [miura a, otani k, miyai h, fukushima h, matsuishi k. post‐acute covid‐19 syndrome with severe sexually deviant behavior. neuropsychopharmacol rep. 2022]
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496059/
https://www.ncbi.nlm.nih.gov/pubmed/37151180
http://dx.doi.org/10.1002/npr2.12343